E. Teixeira

Detection of rare and novel EGFR mutations in NSCLC patients: Implications for treatment-decision

A. M. DE SOUSA, Catarina Silveira, Ana Janeiro et al. · Lung Cancer · 2019 · 56 citations · Full text

Medicine, Molecular Genetics, Oncology +16

Management of infusion-related reactions in cancer therapy: strategies and challenges

Ana Barroso, F. Estevinho, Venceslau Hespanhol et al. · ESMO Open · 2024 · 42 citations · Full text

Pharmacy, Oncology, Pharmacology +16

Clinically relevant bleeding in cancer patients treated for venous thromboembolism from the CATCH study

Pieter W. Kamphuisen, A.Y.Y. Lee, Guy Meyer et al. · Journal of Thrombosis and Haemostasis · 2018 · 40 citations · Full text

Medicine, Hematology, Oncology +17

Real-world data from the Portuguese Nivolumab Expanded Access Program (EAP) in previously treated Non Small Cell Lung Cancer (NSCLC)

Ana Figueiredo, Maria Amélia Almeida, Teresa Almodôvar et al. · Pulmonology · 2019 · 27 citations · Full text

Medicine, Oncology, Pharmacology +17

An economic analysis of erlotinib, docetaxel, pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer

António Araújo, B. Parente, Renato Sotto‐Mayor et al. · Revista Portuguesa de Pneumologia · 2008 · 23 citations · Full text

Medicine, Oncology, Pharmacoeconomics +14